Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease:International Randomised Controlled
BMJ 318:633-640, 615, Rosler,M.,et al, 1999
Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999
Interactive Effects of Age & Brain Disease on Reaction Time
Arch Neurol 34:369, Benton,A.L., 1977
Health Outcomes 1 Year After Subarachonid Hemorrhage
Neurol 55:658-662, Hackett,M.L. et al, 2000
Long-Term Postoperative Cognitive Dysfunction in the Elderly:ISPOCD1 Study
Lancet 351:857-861, Moller,J.T.,et al, 1998
Recovery Following Lateral Medullary Infarction
Neurol 50:1418-1422, Nelles,G.,et al, 1998
Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
NEJM 339:1105-1111, Limousin,P.,et al, 1998
A Prediction Model for Functional Recovery in Stroke
Stroke 28:550-556, Stineman,M.G.,et al, 1997
Herpes Simplex Encephalitis Treated with Acyclovir:Diagnosis and Long Term Outcome
JNNP 63:321-326, McGrath,N.,et al, 1997
Impact of Thalamic Hematoma on Six-Month Mortality and Motor and Cognitive Functional Outcome
Stroke 26:620-626, Mori,S.,et al, 1995
Influence of Age on Stroke Outcome:Copenhagen Stroke Study
Stroke 25:808-813, Nakayama,H.,et al, 1994
Can Sensory Stimulation Improve the Functional Outcome in Stroke Patients?
Neurol 43:2189-2192, Johansson,K.,et al, 1993
Bilateral Fetal Mesencephalic Grafting in Two Patients with Parkinsonism Induced by MPTP
NEJM 327:1556-1563, 15891992., Widner,H.,et al, 1992